Bio Protocol (BIO) continues to trade around $0.03242, showing steady short-term strength after a sharp increase in activity ...
TheFly reported on April 7 that Citigroup lowered its rating on BIO from Buy to Neutral and reduced its price target from ...
Bio-Rad Laboratories, Inc. (BIO) has experienced a rise in revenue growth in recent years thanks to strong sales of its Western Blotting, Digital PCR, and Process Media life science products. Several ...
Bio-Rad Laboratories, Inc., a global leader in life science research and clinical diagnostics products, today announced the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results